Jean-Luc M. Lemercier is CVP & EMEACLA and JAPAC at Edwards Lifesciences Corp (EW). They have made 18 open-market trades across 1 company since 2018, most recently 2024-07-07.
CIK 0001710625
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EW | 184,685 | $16.0M |
Shares reported on the most recent Form 4, priced at the 2024-07-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EW | SELL · 10b5-1 | 2024-05-01 | 2024-05-01 | $84.22 | $2.4M | -0.2% | +2.3% | -25.0% |
| EW | SELL · 10b5-1 | 2024-04-08 | 2024-04-08 | $92.32 | $2.6M | -6.4% | -7.9% | -0.5% |
| EW | SELL · 10b5-1 | 2024-03-11 | 2024-03-11 | $91.68 | $1.3M | +4.5% | +1.0% | -4.9% |
| EW | SELL · 10b5-1 | 2023-05-09 | 2023-05-09 | $88.68 | $1.2M | -1.4% | -5.9% | -10.5% |
| EW | SELL · 10b5-1 | 2023-04-06 | 2023-04-06 | $83.10 | $552K | +3.8% | +6.8% | +9.2% |
| EW | SELL | 2023-03-08 | 2023-03-08 | $76.95 | $1.0M | +4.2% | +6.3% | +9.5% |
| EW | SELL | 2022-05-09 | 2022-05-10 | $98.24 | $2.3M | -0.2% | -1.0% | +11.6% |
| EW | SELL | 2022-04-08 | 2022-04-11 | $123.29 | $2.9M | -3.2% | -23.7% | -20.8% |
| EW | SELL | 2022-03-11 | 2022-03-11 | $106.01 | $2.5M | +2.9% | +16.6% | -10.1% |
| EW | SELL · 10b5-1 | 2021-11-29 | 2021-11-29 | $110.58 | $11K | +9.3% | +18.7% | +2.1% |
| EW | SELL | 2021-04-01 | 2021-04-01 | $83.66 | $2.2M | +1.6% | +11.4% | +22.0% |
| EW | SELL | 2021-03-01 | 2021-03-01 | $84.72 | $2.2M | -3.5% | -2.7% | +10.6% |
| EW | SELL | 2021-02-01 | 2021-02-01 | $83.51 | $3.4M | +7.1% | +2.5% | +15.1% |
| EW | SELL | 2021-01-04 | 2021-01-04 | $91.24 | $3.7M | -1.5% | -5.6% | -3.5% |
| EW | SELL | 2020-04-27 | 2020-04-27 | $223.50 | $776K | -0.1% | -0.8% | +8.2% |
| EW | SELL | 2020-04-01 | 2020-04-01 | $180.84 | $1.3M | +26.3% | +22.3% | +21.1% |
| EW | SELL | 2020-02-27 | 2020-02-27 | $217.53 | $1.5M | -2.4% | -5.6% | +4.1% |
| EW | SELL | 2020-02-03 | 2020-02-03 | $219.50 | $762K | +1.4% | -2.7% | -7.4% |
| EW | SELL | 2019-05-06 | 2019-05-07 | $176.17 | $1.5M | -3.0% | +0.7% | +17.3% |
| EW | SELL | 2019-04-09 | 2019-04-09 | $188.23 | $1.6M | -6.0% | -4.4% | -1.5% |
| EW | SELL | 2019-03-25 | 2019-03-25 | $188.60 | $1.6M | -0.8% | -6.8% | +0.5% |
| EW | SELL | 2018-05-09 | 2018-05-10 | $134.91 | $1.5M | +0.1% | +7.2% | +2.4% |
| EW | SELL | 2018-04-11 | 2018-04-12 | $139.42 | $1.6M | -4.0% | -1.6% | +3.1% |
| EW | SELL | 2018-03-07 | 2018-03-08 | $136.29 | $1.5M | +1.5% | -1.4% | +1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.